Brief: Clearmind Medicine Files U.S. Patent Application For Psychedelic-Based Treatment For Eating Disorders
10/04/2024 12:20
April 10 (Reuters) - Clearmind Medicine Inc CMND.O :
* CLEARMIND MEDICINE FILES U.S. PATENT APPLICATION FOR
PSYCHEDELIC-BASED TREATMENT FOR EATING DISORDERS
Source text for Eikon: ID:nGNX6L2xPf
Further company coverage: CMND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM